Myocardial protection by recombinant soluble P-selectin glycoprotein ligand-1: Suppression of neutrophil and platelet interaction following ischemia and reperfusion

Sang-Soo HAM; Yoon-Young JANG; Jin-Ho SONG; Hyang-Mi LEE; Kwang-Joon KIM; Jun-Sik HONG; Yong-Kyoo SHIN; Sang-Soo HAM; Yoon-Young JANG; Jin-Ho SONG; Hyang-Mi LEE; Kwang-Joon KIM; Jun-Sik HONG; Yong-Kyoo SHIN; Sang-Soo HAM; Yoon-Young JANG; Jin-Ho SONG; Hyang-Mi LEE; Kwang-Joon KIM; Jun-Sik HONG; Yong-Kyoo SHIN.
The Korean Journal of Physiology and Pharmacology ; : 515-523, 2000.
Artículo en Inglés | WPRIM | ID: wpr-728123

Documentos relacionados

  1. How E-, L-, and P-Selectins Bind to sLe<sup>x</sup> and PSGL-1: A Quantification of Critical Residue Interactions.
  2. Inhibition of mitochondrial calcium transporters alters adp-induced platelet responses.
  3. Quantitative interpretation of cell rolling velocity distribution.
  4. Reduced Monocyte and Neutrophil Infiltration and Activation by P-Selectin/CD62P Inhibition Enhances Thrombus Resolution in Mice.
  5. Platelets: Lone Rangers of Inflammatory Signaling in the Lung.
  6. Coronary artery bypass grafting (CABG) induces pro-inflammatory and immunomodulatory phenotype of platelets in the absence of a pro-aggregatory state.
  7. Dynamic <i>in vitro</i> hemocompatibility of oligoproline self-assembled monolayer surfaces.
  8. Platelet procoagulant potential is reduced in platelet concentrates ex vivo but appears restored following transfusion.
  9. Impact of P-selectin-PSGL-1 Axis on Platelet-Endothelium-Leukocyte Interactions in Fatal COVID-19.
  10. Total Synthesis of a PSGL-1 Glycopeptide Analogue for Targeted Inhibition of P-Selectin.